Catherine Lagord

713 total citations
16 papers, 561 citations indexed

About

Catherine Lagord is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Catherine Lagord has authored 16 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Catherine Lagord's work include Muscle Physiology and Disorders (5 papers), Global Cancer Incidence and Screening (3 papers) and Health Promotion and Cardiovascular Prevention (3 papers). Catherine Lagord is often cited by papers focused on Muscle Physiology and Disorders (5 papers), Global Cancer Incidence and Screening (3 papers) and Health Promotion and Cardiovascular Prevention (3 papers). Catherine Lagord collaborates with scholars based in United Kingdom, France and United States. Catherine Lagord's co-authors include Martin Berry, Ann Logan, Isabelle Martelly, Matija Daniel, Jean Gautron, Yann Bassaglia, Georgia Barlovatz‐Meimon, Sylvie Bonavaud, Daniel Hantaı̈ and François Rieger and has published in prestigious journals such as Biochemical and Biophysical Research Communications, British Journal of Cancer and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Catherine Lagord

16 papers receiving 548 citations

Peers

Countries citing papers authored by Catherine Lagord

Since Specialization

Citations

This map shows the geographic impact of Catherine Lagord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Lagord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Lagord more than expected).

Fields of papers citing papers by Catherine Lagord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Lagord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Lagord. The network helps show where Catherine Lagord may publish in the future.

Co-authorship network of co-authors of Catherine Lagord

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Lagord. A scholar is included among the top collaborators of Catherine Lagord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Lagord. Catherine Lagord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	The Impact and Perception of England’s Web-Based Heart Age Test of Cardiovascular Disease Risk: Mixed Methods Study 2023 ·JMIR Cardio ·Victoria Riley, Christopher Gidlow, (unknown), Catherine Lagord, Katherine Thompson, (unknown), (unknown), (unknown), (unknown)	2
2	Evaluation of the uptake and delivery of the NHS Health Check programme in England, using primary care data from 9.5 million people: a cross-sectional study 2020 ·BMJ Open ·Riyaz Patel, Sharmani Barnard, Katherine Thompson, Catherine Lagord, (unknown), (unknown), Tim Evans, (unknown), Julian Flowers, (unknown), (unknown), Nilesh J. Samani, John Robson, (unknown), John Deanfield, (unknown)	38
3	The use of surgery in the treatment of ER+ early stage breast cancer in England: Variation by time, age and patient characteristics 2016 ·European Journal of Surgical Oncology ·Paul Richards, Sue Ward, Jenna Morgan, Catherine Lagord, Malcolm Reed, Karen Collins, Lynda Wyld	21
4	Online self-assessment of cardiovascular risk using the Joint British Societies (JBS3)-derived heart age tool: a descriptive study 2016 ·BMJ Open ·Riyaz Patel, Catherine Lagord, (unknown), (unknown), Mike Knapton, John Deanfield	27
5	A population based study of variations in operation rates for breast cancer, of comorbidity and prognosis at diagnosis: Failure to operate for early breast cancer in older women 2014 ·European Journal of Surgical Oncology ·T Bates, T. Evans, Catherine Lagord, I. Monypenny, Olive Kearins, Gill Lawrence	23
6	Clinical outcome data for symptomatic breast cancer: the breast cancer clinical outcome measures (BCCOM) project 2009 ·British Journal of Cancer ·T Bates, Olive Kearins, I. Monypenny, Catherine Lagord, (unknown)	16
7	High CSF transforming growth factor levels after subarachnoid haemorrhage: association with chronic communicating hydrocephalus 2008 ·Journal of Neurology Neurosurgery & Psychiatry ·Michael R. Douglas, Matija Daniel, Catherine Lagord, (unknown), Andrea Parolin Jackowski, Carly Cooper, Martin Berry, Ann Logan	56
8	O-6 Three years of the Breast Cancer Clinical Outcome Measures (BCCOM) project 2007 ·European Journal of Cancer Supplements ·I. Monypenny, Catherine Lagord, Olive Kearins, Gavin P. Lawrence	1
9	Expression of TGFβ2 but Not TGFβ1 Correlates with the Deposition of Scar Tissue in the Lesioned Spinal Cord 2002 ·Molecular and Cellular Neuroscience ·Catherine Lagord, Martin Berry, Ann Logan	108
10	Transforming Growth Factor-β1 in the Cerebrospinal Fluid of Patients with Subarachnoid Hemorrhage: Titers Derived from Exogenous and Endogenous Sources 2001 ·Journal of Cerebral Blood Flow & Metabolism ·(unknown), (unknown), Catherine Lagord, Matija Daniel, Martin Berry, (unknown), Ann Logan	55
11	Increased synthesis of heparin affin regulatory peptide in the perforant path lesioned mouse hippocampal formation 2000 ·Experimental Brain Research ·Frantz Rom Poulsen, Catherine Lagord, (unknown), E Pedersen, Denis Barritault, Bente Finsen	19
12	Differential myogenicity of satellite cells isolated from extensor digitorum longus (EDL) and soleus rat muscles revealed in vitro 1998 ·Cell and Tissue Research ·Catherine Lagord, (unknown), Sylvie Bonavaud, Yann Bassaglia, (unknown), Georgia Barlovatz‐Meimon, Jean Gautron, Isabelle Martelly	88
13	The kinase inhibitor iso-H7 stimulates rat satellite cell differentiation through a non-protein kinase C pathway by increasing myogenin expression level 1996 ·Cell Biology and Toxicology ·Catherine Lagord, Marie-Pierre Leibovitch, Gilles Carpentier, Serge A. Leibovitch, Isabelle Martelly	9
14	Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease 1995 ·Journal of the Neurological Sciences ·Daniel Hantaı̈, Mohammed Akaaboune, Catherine Lagord, Monique Murawsky, Lucien J. Houenou, Barry W. Festoff, (unknown), François Rieger, (unknown)	80
15	Satellite Cell Myogenesis Is Highly Stimulated by the Kinase Inhibitor Iso-H7: Comparison with HA1004 and Staurosporine Effects 1993 ·Biochemical and Biophysical Research Communications ·Catherine Lagord, Gilles Carpentier, Jerzy Moraczewski, G. Pons, F. Climent, Isabelle Martelly	14
16	Stimulation of rat satellite cell myogenesis by inhibitors of ser/thr protein kinases 1993 ·Neuromuscular Disorders ·Catherine Lagord, Gilles Carpentier, Marie-Pierre Leibovitch, Jean Gautron, Isabelle Martelly	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact